YAP1 and cancer: Of critical relevance to cancers beyond CRC, we show that a core of the YAP/TAZ-fueled deregulated enhancers is consistently active in diverse tumor types crossing the cellular and molecular divides of tissue of origin, genetic aberrations, and microenvironmental stimuli.